Bluett RJ et al. |
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation. |
2014 |
Transl Psychiatry |
pmid:25004388
|
Dong W et al. |
Simulation of Swanson's literature-based discovery: anandamide treatment inhibits growth of gastric cancer cells in vitro and in silico. |
2014 |
PLoS ONE |
pmid:24949851
|
Wiley JL et al. |
Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. |
2014 |
Eur. J. Pharmacol. |
pmid:24858366
|
Pietrzak RH et al. |
Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors. |
2014 |
Neuropsychopharmacology |
pmid:24820537
|
Ravi J et al. |
FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway. |
2014 |
Oncotarget |
pmid:24811863
|
Hama AT et al. |
Fatty acid amide hydrolase (FAAH) inhibitors exert pharmacological effects, but lack antinociceptive efficacy in rats with neuropathic spinal cord injury pain. |
2014 |
PLoS ONE |
pmid:24788435
|
Al Kury LT et al. |
Effects of the endogenous cannabinoid anandamide on voltage-dependent sodium and calcium channels in rat ventricular myocytes. |
2014 |
Br. J. Pharmacol. |
pmid:24758718
|
Nader J et al. |
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. |
2014 |
Neuropharmacology |
pmid:24709540
|
Kaczocha M et al. |
Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia. |
2014 |
PLoS ONE |
pmid:24705380
|
Sun LJ et al. |
Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication. |
2014 |
Int. J. Infect. Dis. |
pmid:24704332
|
Pertwee RG |
Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications. |
2014 |
Proc Nutr Soc |
pmid:24135210
|
Ohno-Shosaku T and Kano M |
Endocannabinoid-mediated retrograde modulation of synaptic transmission. |
2014 |
Curr. Opin. Neurobiol. |
pmid:24747340
|
Chianese R et al. |
Hypothalamus-pituitary axis: an obligatory target for endocannabinoids to inhibit steroidogenesis in frog testis. |
2014 |
Gen. Comp. Endocrinol. |
pmid:24566122
|
Zheng Y et al. |
Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system. |
2014 |
Eur. J. Pharmacol. |
pmid:24508383
|
Al Kury LT et al. |
Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes. |
2014 |
Cell Calcium |
pmid:24472666
|
Björklund E et al. |
Ketoconazole inhibits the cellular uptake of anandamide via inhibition of FAAH at pharmacologically relevant concentrations. |
2014 |
PLoS ONE |
pmid:24466356
|
Yu S et al. |
Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in the brain. |
2014 |
J. Biol. Chem. |
pmid:24644281
|
Mahavadi S et al. |
Inhibitory signaling by CB1 receptors in smooth muscle mediated by GRK5/β-arrestin activation of ERK1/2 and Src kinase. |
2014 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:24407588
|
Jackson AR et al. |
Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1. |
2014 |
J. Leukoc. Biol. |
pmid:24319288
|
Okura D et al. |
The endocannabinoid anandamide inhibits voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 in Xenopus oocytes. |
2014 |
Anesth. Analg. |
pmid:24557103
|